Home > Healthcare > Medical Devices > Diagnostic Devices > malaria diagnostics market
Get a free sample of Malaria Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Malaria Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The malaria diagnostics sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command significant influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
Some of the eminent market participants operating in the malaria diagnostics industry include:
Abbott Laboratories, Access Bio, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher corporation, F. Hoffmann-La Roche Ltd, and Nikon Corporation among others.
U.S. malaria diagnostics market size reached USD 303.1 million in 2023, driven by increasing population and aging demographics.
The kits & reagents product segment in the malaria diagnostics industry held a decent share in 2023 and will reach USD 857.4 million by 2032, propelled by the ongoing advancements in diagnostic technologies.
Malaria diagnostics market size was valued at USD 819.1 million in 2023 and is estimated to grow at 5% CAGR from 2024 to 2032, driven by rising malaria transmission and prevention awareness.